●●●●● CONTENTS ●●●● ●●0 ●●● ●●●● I. The rationale for extended-release pharmaceuticals ll. Terminology II. Extended-release oral dosage forms IV Delayed-release oral dosage forms V USP requirements and FDA Guidance for modified-release dosage forms VI Clinical considerations in the use of oral modified-release dosage form VI. Packaging and storing modified-release tablets and capsulesCONTENTS I. The rationale for extended-release pharmaceuticals II. Terminology III. Extended-release oral dosage forms IV. Delayed-release oral dosage forms V. USP requirements and FDA Guidance for modified-release dosage forms VI. Clinical considerations in the use of oral modified-release dosage form VII. Packaging and storing modified-release tablets and capsules